[Knoxville, TN], August 9, 2021 – 490 BioTech and NellOne Therapeutics, Inc., two leaders in Tennessee’s thriving entrepreneurial community and members of its growing biotechnology cluster, announced today they are expanding their partnership to fight against acute...

Dr. Cymbeline T. (Bem) Culiat, Co-Founder and Chief Science Officer for NellOne Therapeutics, Inc. (NellOne), along with pediatrician, and public health expert, Dr. Jennie A. McLaurin, co-authored a groundbreaking book,

Small Business Innovation Research Program Provides Seed Funding for R&D [Knoxville, TN], April 26, 2021 – NellOne Therapeutics, Inc. (NellOne) has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase I grant for...

The novel coronavirus is no doubt top of mind for most people with the infection numbers rising rapidly on a daily, so an announcement last week from Oak Ridge National Laboratory (ORNL) that involves a local early stage biopharmaceutical...

NellOne Therapeutics of Knoxville, Tenn., has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19. The technology...

By Sarah Marshall, Uniformed Services University of the Health Sciences WASHINGTON -- Efforts are underway at the Uniformed Services University of the Health Sciences to support the fight against the pandemic, including some that apply existing research and knowledge...

You don't want to miss this interview by Brandon Bruce of Startup Knox with Knoxville serial entrepreneur Bill Malkes about his newest company NellOne Therapeutics. Click to view podcast on original website

NellOne Therapeutics Inc., the early stage biopharmaceutical company using a talented protein to plot a new future for regenerative medicine, today announced that the United States Patent and Trademark Office (“USPTO”) yesterday issued U.S. Patent No. 10,752,663 with...

NellOne Therapeutics Inc., the early stage biopharmaceutical company pioneering advances in regenerative medicine, will open a new research and development laboratory in Knox County, it was announced today. The facility will enable NellOne to add up to 20 new jobs...

NellOne Therapeutics Inc., the early stage biopharmaceutical company using a talented protein to plot a new future for regenerative medicine, announced today the filing of a provisional patent application around the usage of the NELL1 signaling protein in the...

NellOne Therapeutics Inc., the early stage biopharmaceutical company using a talented protein to plot a new future for regenerative medicine, has appointed accomplished leader and entrepreneur William A. Malkes as its new Chief Executive Officer. NellOne Therapeutics...